WT1 and FAK in a pathological mechanism of daibetes nephropathy
WT1 and FAK in a pathological mechanism of daibetes nephropathy
批准号:
09671149
负责人:
MIMURA Toshihide
金额:
$2.05万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998
中文摘要
1)初步数据显示,糖尿病肾病(DN)肾组织中肾小球上皮细胞(GECs)数量减少,而p125粘着斑激酶(FAK)和WT1在各GEC中的表达与正常肾脏基本相同。2)对27例新近开始血液透析(HD)治疗的终末期肾病(ESRD)患者进行了WT1基因突变分析。虽然ESRD患者只有内含子突变增加的趋势,但差异无统计学意义。为了分析WT1的mRNA突变,我的实验室开发了一项新技术(提交)。用套式RT-PCR法从患者尿沉渣中获得WT1基因,在大约40%的糖尿病患者中检测到尿WT1基因,而在无蛋白尿的糖尿病患者中只有2%的患者检测到尿蛋白WT1基因。惊人的数据表明,GEC的损害是由…发展而来的糖尿病肾病和尿WT I检测有可能取代有创肾活检而成为显示肾损害的新技术。本实验室利用尿WT1基因进行了广泛的突变搜索。3)FAK和WT1在培养的GEC中的表达模式不同于在体GEC和新鲜分离的GEC(制备中)。GEC的长期原代培养是通过在一种已知会降低WT1功能的化学物质的存在下培养而建立的。4)利用FAK阴性的成纤维细胞,我们发现在肾脏中高表达的FAK家族成员Cake在整合素信号转导中可以发挥与FAK相似的作用(Ueki,Mimura等)。Febs Letter,1998)5)正如我们所报道的,在蛋白尿出现之前,OLETF,自发发育的DM大鼠系,肾小球中FAK的表达和酪氨酸磷酸化增加。提示高滤过致肾小管上皮细胞机械应激可诱导FAK表达和酪氨酸磷酸化。血管紧张素转换酶抑制剂(ACE-I)是否可通过降低肾小球内高压来抑制OLETF中FAK的升高。与对照组相比,只有高剂量的ACE-I能显著抑制肾小球FAK的表达。这些数据表明,糖尿病引起的高滤过诱导FAK的表达和酪氨酸磷酸化,这可能是糖尿病肾病的病理机制之一。这项拨款的支持给我们的实验室和医学生物学领域带来了一些新的研究成果和新的问题。较少
英文摘要
1) The number of glomerular epithelial cells (GECs) was reduced in diabetes nephropathy (DN) kidney as preliminary data shown, however, the expression of p125 Focal adhesion kinase (FAK) and WT1 was almost equal in each GEC to normal kidneys. These data suggest that the expression level of FAK and WT1 in GECs was not significantly reduced in DN.2) The mutation in genomic WT1 gene was analyzed in 27 end-stage renal disease (ESRD) patients who recently started hemodialysis (HD) treatment. Although there were tendency of increased mutations only in introns in ESRD patients, it was not statistically significant. To analyze mutations in mRNA of WT1, a new technique was developed in my laboratory (submitted). Briefly WT1 cDNA was obtained from patient urine sediments using nested-RT-PCR.Urine WT1 cDNA was detected in approximately 40% DN patients, on the other hand in only 2% diabetes mellitus (DM) patients without proteinuria (submitted). The striking data suggest that GEC damage was develo … More ped in DN and the detection of urine WT I could be the novel technique to show renal damage replacing invasive renal biopsy. Utilizing urine WT1 cDNA the extensive mutation search has been in progress in my laboratory.3) The expression pattern of FAK and WT1 in cultured GEC line was different from that in in vivo-GEC or freshly isolated GEC (in preparation). Long term primary culture of GEC has been established by culturing in the presence of a chemical which is known to reduce WT1 function. Biology of GEC obtained by this method has been studied.4) Using FAK negative fibroblasts, we showed that Cake, a member of FAK family kinase highly expressed in kidney, could play a similar role of FAK in integrin siganl transduction (Ueki, Mimura et al. FEBS letter, 1998).5) As we have reported, the expression and tyrosine phosphorylation of FAK increase in glomeruli of OLETF, spontaneous developing DM rat strain, before presence of proteinuria. It could suggest that mechanical stress of GEC due to hyperfiltration induces the FAK expression and tyrosine phosphorylation. It was of interest whether angiotensin converting enzyme inhibitor (ACE-I) could suppress the elevation of FAK in OLETF by reducing intraglomeruli hypertension. Only high dose ACE-I significantly suppressed the increase of expression of FAK in OLETF glomeruli comparing to that of controls (in preparation). These data suggested that hyperfiltration due to diabetes induced expression and tyrosine phosphorylation of FAK which could be at least a part of the pathological mechanism of DN.The support of this grant has brought to our laboratory and to the medical biology Field several new research results as well as new questions. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Ueki, K., Mimura, T., Nakamoto, T., Sasaki, T., Aizawa, S., Hirai, H., Yano, S., Naruse, T., and Nojima, Y.: "Integrin-mediated signal transduction in cells lacking focal adhesion kinase p125FAK." FEBS letters. 432. 197-201 (1998)
Ueki, K.、Mimura, T.、Nakamoto, T.、Sasaki, T.、Aizawa, S.、Hirai, H.、Yano, S.、Naruse, T. 和 Nojima, Y.:“整合素介导
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kanda, H., Mimura, T., Morino, N., Hamasaki, K., Nakamoto, T., Hirai, H.Morimoto, C., Yazaki, Y., and Nojima, Y.: "Ligation of the T cell antigen receptor induces tyrosine phosphorylation of p105CasL,member of the p130Cas-related docking protein family, a
Kanda, H.、Mimura, T.、Morino, N.、Hamasaki, K.、Nakamoto, T.、Hirai, H.Morimoto, C.、Yazaki, Y. 和 Nojima, Y.:“T 的结扎
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Mimura,T.,Minota,S.,et al.: "Constitutive tyrosine phosphorylation of the vav proto-oncogene product in MRL/Mp-lpr/lpr mice." J.Immunol.158. 2977-2983 (1997)
Mimura,T.,Minota,S.,et al.:“MRL/Mp-lpr/lpr 小鼠中 vav 原癌基因产物的组成型酪氨酸磷酸化。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hamasaki, K., Mimura, T., Kanda, H., Morino, N., Yazaki, Y., and Nojima, Y.: "Development of systemic lupus erythematosus in a rheumatoid arthritis patient with anti-ribosomal P protein antibody." Lupus. 6. 734-736 (1997)
Hamasaki, K.、Mimura, T.、Kanda, H.、Morino, N.、Yazaki, Y. 和 Nojima, Y.:“类风湿性关节炎患者使用抗核糖体 P 蛋白抗体发展为系统性红斑狼疮。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
pathogenic changes in histone modification and DNA methylation in synovial fibroblasts from RA joints
-
批准号:22591083
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.75万
-
财政年份:2010
-
负责人:MIMURA Toshihide
-
依托单位:
国内基金
海外基金
登录
查看更多内容
USP9X介导蜕膜化基质细胞内WT1去泛素化激活IL-15依赖的dNK募集在URPL中的功能及机制研究
-
批准号:2025JJ60833
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:廖婧男
-
依托单位:
WT1棕榈酰化修饰诱导乳酸生成促进白血病微环境巨噬细胞M2极化的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:龙梓洁
-
依托单位:
靶向ALKBH5联合mRNA疫苗激活WT1特异性CTLs清除AML细胞
的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:李冉
-
依托单位:
ARID5A通过调控PHF1募集及组蛋白H3K27甲基化修饰介导WT1转录抑制在低氧性肺动脉高压中的作用及机制研究
-
批准号:82371882
-
项目类别:面上项目
-
资助金额:50万元
-
批准年份:2023
-
负责人:龙洋
-
依托单位:
p62招募FBXW7诱导WT1蛋白的选择性自噬降解促进有腔卵泡形成的机制研究
-
批准号:82360296
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2023
-
负责人:何美娜
-
依托单位:
转录因子WT1介导孕酮受体PR活性参与子宫接受态建立和胚胎着床的机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2022
-
负责人:涂兆伟
-
依托单位:
WT1 基因在糖皮质激素所致腹型肥胖中的作用研究
-
批准号:2022JJ30792
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:杨芝春
-
依托单位:
miR-590/Wt1/Sf1信号介导孕期咖啡因暴露所致睾丸发育毒性的宫内起源机制
-
批准号:82160712
-
项目类别:地区科学基金项目
-
资助金额:34万元
-
批准年份:2021
-
负责人:张棋
-
依托单位:
TET2的调控及其介导的m5C WT1甲基化在狼疮肾炎足细胞损伤中的机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:周华
-
依托单位:
miR-590/Wt1/Sf1信号介导孕期咖啡因暴露所致睾丸发育毒性的宫内起源机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:
-
依托单位: